Common heart pill may hold key to stopping liver cancer
NCT ID NCT02968810
Summary
This study is testing if a widely used cholesterol-lowering drug called simvastatin can help prevent liver cancer in people who already have liver cirrhosis (scarring). It involves 52 participants who will take either the drug or a placebo (sugar pill) daily for 6 months. Researchers will track changes in blood markers and liver health to see if the drug slows the progression from cirrhosis to cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Centro Comprensivo de Cancer de UPR
San Juan, 00927, Puerto Rico
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Puerto Rico
San Juan, 00936, Puerto Rico
Conditions
Explore the condition pages connected to this study.